Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric oncology patients. Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2023
CompletedFirst Posted
Study publicly available on registry
November 7, 2023
CompletedStudy Start
First participant enrolled
November 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2026
May 1, 2026
April 1, 2026
2.9 years
November 2, 2023
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Nausea and vomiting
Nausea and Vomiting Thermometer Scale in Children with Cancer is a 5-likert type scale. An increase in the score indicates an increase in the degree of nausea and vomiting experienced by children with cancer.
30 minutes before the procedure, halfway through the chemotherapy infusion, immediately after the procedure, and for the first 24 hours after the end of chemotherapy
Secondary Outcomes (5)
Heart rate
30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure,
Systolic and diastolic blood pressure
30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure
Respiratory rate
30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure
Body temperature
30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure
Oxygen saturation
change from baseline 60 minutes of chemotherapy infusion
Study Arms (2)
Guided imagery group
EXPERIMENTALParticipants will receive guided imagery intervention.
Control
NO INTERVENTIONParticipants will receive routine care.
Interventions
The children in the experimental group will listen to the first part of the 'Guided Imagery CD' prepared by the Turkish Psychological Association for relaxation 30 minutes before the chemotherapy infusion starts. The suggestions given in the first part of the CD will help the patients relax and focus their attention on their breathing. Patients will be positioned in a supine or semi-fowler position and will listen to the CD with headphones from a laptop. Once the chemotherapy infusion starts, relaxing light background music with the sound of a river or sea will be played based on the patients' preference, and imagery will be applied to the patients. Patients will be encouraged to think of various images, such as imagining that the treatment is over, visualizing themselves as much healthier and recovering quickly, returning to their old life, and doing whatever they want to do first after recovery. If there is an object, person, event, situation, or food that will make them feel good,
Eligibility Criteria
You may qualify if:
- to 18 years old,
- who will receive intravenous chemotherapy,
- no cognitive or neurological disease that would prevent communication,
- receiving a chemotherapy protocol with a high or moderate emetogenic effect according to the MASCC/ESMO Antiemetic Guideline Classification,
- no verbal, visual and auditory communication disabilities (ability to speak Turkish, no mental deficiency),
- children whose parents and themselves volunteered to participate in the study
You may not qualify if:
- Children receiving radiotherapy,
- taking ginger powder or vitamins to reduce nausea,
- children who did not want to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hacettepe Universitycollaborator
- Baskent Universitylead
Study Sites (1)
Hacettepe University İhsan Doğramacı Hospital
Ankara, Ankara, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayşe Ay, RN, PhD
Baskent University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participant will be randomly assigned to groups. An independent statistician will analyze the data.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- RN, PhD, Assistant Professor
Study Record Dates
First Submitted
November 2, 2023
First Posted
November 7, 2023
Study Start
November 10, 2023
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
October 30, 2026
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
the data wil be shared upon a reasonable request.